CN105362315B - 一种东革阿里提取物及其制备方法 - Google Patents
一种东革阿里提取物及其制备方法 Download PDFInfo
- Publication number
- CN105362315B CN105362315B CN201510906420.0A CN201510906420A CN105362315B CN 105362315 B CN105362315 B CN 105362315B CN 201510906420 A CN201510906420 A CN 201510906420A CN 105362315 B CN105362315 B CN 105362315B
- Authority
- CN
- China
- Prior art keywords
- eurycoma longifolia
- extract
- longifolia extract
- methanol
- eurycoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000284 extract Substances 0.000 title claims abstract description 52
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 240000005739 Eurycoma longifolia Species 0.000 title claims description 69
- 238000000605 extraction Methods 0.000 title claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000011347 resin Substances 0.000 claims abstract description 10
- 229920005989 resin Polymers 0.000 claims abstract description 10
- 238000001035 drying Methods 0.000 claims abstract description 7
- 229930182470 glycoside Natural products 0.000 claims abstract description 7
- 239000000463 material Substances 0.000 claims abstract description 7
- 239000003480 eluent Substances 0.000 claims abstract description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 61
- 238000001914 filtration Methods 0.000 claims description 3
- -1 eleutherol glycoside Chemical class 0.000 claims description 2
- 238000011068 loading method Methods 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- KNLHGXVYZRQSJZ-UHFFFAOYSA-N Eleutherol Natural products OC1=C2C(OC)=CC=CC2=CC2=C1C(C)OC2=O KNLHGXVYZRQSJZ-UHFFFAOYSA-N 0.000 claims 1
- 150000002576 ketones Chemical class 0.000 abstract description 9
- 229920005610 lignin Polymers 0.000 abstract description 6
- 150000002338 glycosides Chemical class 0.000 abstract description 5
- 235000011203 Origanum Nutrition 0.000 abstract 3
- 241001529744 Origanum Species 0.000 abstract 3
- 238000000034 method Methods 0.000 description 17
- 150000001875 compounds Chemical class 0.000 description 14
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 9
- 238000000926 separation method Methods 0.000 description 9
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 8
- 230000005764 inhibitory process Effects 0.000 description 8
- 238000000746 purification Methods 0.000 description 7
- 238000005481 NMR spectroscopy Methods 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 238000004237 preparative chromatography Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 210000004881 tumor cell Anatomy 0.000 description 3
- 238000003809 water extraction Methods 0.000 description 3
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- 101001109993 Artemia salina 60S acidic ribosomal protein P2 Proteins 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 208000038016 acute inflammation Diseases 0.000 description 2
- 230000006022 acute inflammation Effects 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- FGXWKSZFVQUSTL-UHFFFAOYSA-N domperidone Chemical compound C12=CC=CC=C2NC(=O)N1CCCN(CC1)CCC1N1C2=CC=C(Cl)C=C2NC1=O FGXWKSZFVQUSTL-UHFFFAOYSA-N 0.000 description 2
- 229960001253 domperidone Drugs 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000581444 Clinidae Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 244000241463 Cullen corylifolium Species 0.000 description 1
- 208000001490 Dengue Diseases 0.000 description 1
- 206010012310 Dengue fever Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 244000042238 Eurycoma Species 0.000 description 1
- LXECYNZTZUUAOY-UHFFFAOYSA-N Longilactone Natural products CC1C(O)C(O)C2C3(C)C(O)C(=O)C=C(C)C3C(O)C4OC(=O)C1(O)C24C LXECYNZTZUUAOY-UHFFFAOYSA-N 0.000 description 1
- 206010057672 Male sexual dysfunction Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- UCUWZJWAQQRCOR-UHFFFAOYSA-N Pasakbumin A Natural products O1C(=O)C(O)C2(O)C(=C)C(O)C3(O)C4C5(C)C(O)C(=O)C=C(C)C5CC1C42CO3 UCUWZJWAQQRCOR-UHFFFAOYSA-N 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- IOSXSVZRTUWBHC-LBTVDEKVSA-N Quassin Chemical compound CC([C@@H]1CC(=O)O[C@@H]([C@]21C)C1)=C(OC)C(=O)[C@@H]2[C@]2(C)[C@@H]1[C@H](C)C=C(OC)C2=O IOSXSVZRTUWBHC-LBTVDEKVSA-N 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000003048 aphrodisiac agent Substances 0.000 description 1
- 230000002509 aphrodisiac effect Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 208000025729 dengue disease Diseases 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- VLOVSFJPGNJHMU-UHFFFAOYSA-N ethanol;methanol;hydrate Chemical compound O.OC.CCO VLOVSFJPGNJHMU-UHFFFAOYSA-N 0.000 description 1
- UCUWZJWAQQRCOR-OKNZMGBLSA-N eurycomanone Chemical compound O1C(=O)[C@H](O)[C@@]2(O)C(=C)[C@@H](O)[C@@]3(O)[C@@H]4[C@@]5(C)[C@H](O)C(=O)C=C(C)[C@@H]5C[C@@H]1[C@]42CO3 UCUWZJWAQQRCOR-OKNZMGBLSA-N 0.000 description 1
- 239000009947 eurycomanone Substances 0.000 description 1
- 238000000105 evaporative light scattering detection Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000005918 in vitro anti-tumor Effects 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000010829 isocratic elution Methods 0.000 description 1
- CCGKOQOJPYTBIH-UHFFFAOYSA-N ketene group Chemical group C=C=O CCGKOQOJPYTBIH-UHFFFAOYSA-N 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- KBBRVTNGCNCUCX-GZKGTQTLSA-N longilactone Chemical compound CC([C@@H]1[C@H]2O)=CC(=O)[C@@H](O)[C@]1(C)[C@H]1[C@@H](O)[C@@H](O)[C@H](C)C3[C@]1(C)[C@@H]2OC3=O KBBRVTNGCNCUCX-GZKGTQTLSA-N 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- IOSXSVZRTUWBHC-UHFFFAOYSA-N quassin Natural products C1C(C23C)OC(=O)CC3C(C)=C(OC)C(=O)C2C2(C)C1C(C)C=C(OC)C2=O IOSXSVZRTUWBHC-UHFFFAOYSA-N 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510906420.0A CN105362315B (zh) | 2015-12-07 | 2015-12-07 | 一种东革阿里提取物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510906420.0A CN105362315B (zh) | 2015-12-07 | 2015-12-07 | 一种东革阿里提取物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105362315A CN105362315A (zh) | 2016-03-02 |
CN105362315B true CN105362315B (zh) | 2020-03-20 |
Family
ID=55365269
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510906420.0A Active CN105362315B (zh) | 2015-12-07 | 2015-12-07 | 一种东革阿里提取物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105362315B (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017181303A1 (zh) * | 2016-04-22 | 2017-10-26 | 北京罗瑞生物科技有限公司 | 东革阿里有效成分的制备方法及其用途 |
CN107303303B (zh) * | 2016-04-22 | 2018-05-11 | 北京罗瑞生物科技有限公司 | 制备东革阿里有效成分及组合应用 |
CN106474322A (zh) * | 2016-12-07 | 2017-03-08 | 黑龙江省科学院大庆分院 | 含有东革阿里提取物的黑蒜多酚口服液及其制备方法 |
WO2018205191A1 (zh) * | 2017-05-11 | 2018-11-15 | 北京罗瑞生物科技有限公司 | 四种苦木素工业制备方法及其制备药品、保健食品新用途 |
CN110496143A (zh) * | 2018-05-17 | 2019-11-26 | 天津中医药大学 | 东革阿里提取物、其制备方法、以及其用途 |
CN109258662B (zh) * | 2018-09-28 | 2021-03-23 | 广东省农业科学院果树研究所 | 植物体内输导的昆虫拒食剂13,21-dihydroeurycomanone及应用 |
CN109535172B (zh) * | 2018-10-19 | 2020-06-05 | 广东省农业科学院果树研究所 | 一种苦木苦味素类化合物及其在制备昆虫拒食剂中的应用 |
CN109315412B (zh) * | 2018-11-09 | 2021-01-12 | 广东省农业科学院果树研究所 | Eurycomanone在昆虫拒食活性和抑制昆虫生长发育的应用 |
CN110749680A (zh) * | 2019-11-12 | 2020-02-04 | 福建省微生物研究所 | 一种快速鉴定东革阿里化学成分的方法 |
CN111249319B (zh) * | 2020-01-17 | 2022-04-19 | 天津国际生物医药联合研究院 | 一种东革阿里提取物的磷脂复合物及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104666373A (zh) * | 2013-11-27 | 2015-06-03 | 周亚伟 | 东革阿里新用途 |
-
2015
- 2015-12-07 CN CN201510906420.0A patent/CN105362315B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104666373A (zh) * | 2013-11-27 | 2015-06-03 | 周亚伟 | 东革阿里新用途 |
Non-Patent Citations (2)
Title |
---|
东革阿里化学成分的分离与鉴定;张毅 等;《沈阳药科大学学报》;20140131;第31卷(第1期);第9-12页 * |
药用植物东革阿里的研究进展;凌敏 等;《广东林业科技》;20131231;第29卷(第6期);第66-73页 * |
Also Published As
Publication number | Publication date |
---|---|
CN105362315A (zh) | 2016-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105362315B (zh) | 一种东革阿里提取物及其制备方法 | |
CN110305092B (zh) | 愈创木烷倍半萜及其制备和应用 | |
CN110818669B (zh) | 沉香四氢2-(2-苯乙基)色酮类化合物及其分离方法和应用 | |
CN103800388A (zh) | 一种黄绿蜜环菌抗氧化活性组分的制备方法及其应用 | |
WO2017219510A1 (zh) | 一种具有抗肿瘤活性和抗炎活性的醌式查尔酮碳苷二聚体化合物及其制备方法 | |
Liu et al. | Anti-inflammatory abietanes diterpenes and triterpenoids isolated from Clinopodium polycephalum | |
CN111253247B (zh) | 一种具有抗炎活性的新酚酸类化合物的制备方法及应用 | |
CN110746421B (zh) | 吲哚单萜类化合物的提取方法及应用 | |
CN108948038B (zh) | 一种新紫檀烷型黄酮类化合物及其用途 | |
CN113214214B (zh) | 关苍术中一种萜类化合物的制备方法和应用 | |
CN113061124B (zh) | 倍半萜二聚体化合物及其制备方法、应用和药物组合物 | |
CN112194704B (zh) | 一种甾体皂苷类化合物及其制备方法和应用 | |
CN111377933B (zh) | 诸葛菜种子提取的生物碱类化合物及其提取方法与应用 | |
CN113527323A (zh) | 一种从白桐树中提取酚类化合物的方法 | |
CN106349021B (zh) | 一种吉祥草中的化合物及其制备与应用 | |
CN107722087B (zh) | 一种绞股蓝黄酮类化合物及其制备与在抗肿瘤药物中的应用 | |
CN106377523B (zh) | 一种天然活性药物及其制备与应用 | |
CN108623645B (zh) | 一种黄酮类化合物及其制备方法与应用 | |
CN105669692B (zh) | 一种苯酞类二聚体化合物的提取方法和用途 | |
CN116333029B (zh) | 一类油茶籽皂苷化合物及其应用 | |
CN109180632A (zh) | 一种从雷公藤中分离出的新化合物及其制备方法和医药用途 | |
CN116730957B (zh) | 一种乌药烷型倍半萜二聚体及其制备方法与应用 | |
RU2783445C1 (ru) | Способ выделения и очистки байкалина из корневых культур шлемника байкальского (scutellaria baicalensis georgi) | |
CN111303185B (zh) | 一种具有抑制肿瘤活性的化合物及其提取方法 | |
CN112300185B (zh) | 肝毒性降低的生物碱类化合物及其制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240201 Address after: Room 1013, Building 1, No. 502 Linping Avenue, Hangzhou Yuhang Economic Development Zone, Linping District, Hangzhou City, Zhejiang Province, 311119 Patentee after: Hangzhou Yirui Pharmaceutical Technology Co.,Ltd. Country or region after: China Address before: 1st Floor, Zhejiang University Changshu Cooperative Research Institute, No. 1-2 Research Institute Road, Economic and Technological Development Zone, Changshu City, Jiangsu Province, 215500 Patentee before: CHANGSHU QIUSHI TECHNOLOGY Co.,Ltd. Country or region before: China |